Benzo(a)pyrene diolepoxide-DNA adducts detected by synchronous fluorescence spectrophotometry. by Vahakangas, K et al.
Environmental Health Perspectives
Vol. 62, pp. 101-104, 1985
Benzo(a)pyrene Diolepoxide-DNA Adducts
Detected by Synchronous Fluorescence
Spectrophotometry
by Kirsi Vahakangas,* Glennwood Trivers,* Marilyn Rowe,*
and Curtis C. Harris*t
Using benzo(a)pyrene (BP) as a model carcinogen we are currently applying a fluorescence technique
to detect the very low levels of carcinogen-DNA adducts in human populations due to environmental
exposure. In synchronous fluorescence spectrophotometry for detection of BP-diol epoxide-DNA, exci-
tation and emission wavelengths are scanned simultaneously with a fixed wavelength difference (A X) of
34 nm. Compared to conventional fluorescence methods only one peak emerges because excitation and
emission peakshavetomatch A Xto show. Because ofthequenching effectofDNA, samples are hydrolyzed
by acid. After this, BP-diol epoxide (BPDE)--modified DNA gives a peak at the same wavelength and of
the same fluorescence yield as BP-tetrols. When DNA from peripheral blood lymphocytes of44 coke oven
workers were analyzed, 10 had a sharp peak at 379. Among 36 coke oven workers from another factory,
4 had detectable levels of adducts. A much smaller percentage of samples was positive in a group of
aluminum plant workers. We have also found BPDE-DNA adducts in DNA from pulmonary alveolar
macrophages and peripheral blood lymphocytes from tobacco smokers and some of the nonsmokers.
Introduction
Because polycyclic aromatic hydrocarbons (PAH) have
highly fluorescent aromatic nucleus, fluorescence has
been used to study the structural features of PAH-
DNA complexes (1-4). This has also led to the idea of
biologic monitoring of PAH exposure by measuring
PAH-DNA adducts in human tissues by fluorescence
(5) (Table 1). The main difficulty is the low level of
environmental exposure compared to animal experi-
ments (6), leading to minute amounts of DNA adducts
formed. Highly sensitive assays are thus needed.
The first important improvement to the conventional
fluorescence methodwasthephoton-countingdevicede-
veloped by Vigny and Duquesne (7). It increased the
signal-to-noise ratio so that very weak fluorescence could
Table 1. Fluorescence methods for PAH-DNA adducts.
Detection limit,
PAH molecules/
Method PAH studied nucleotides Reference
Photoncounting fluorescence 7-Bromomethyl-
spectrophotometry benz(a)anthracene 1/2 x I04 Vigny and Duquesne (7)
Low temperature fluorescence
spectroscopy Benzo(a)pyrene 1/5 x I04 Ivanovic et al. (12)
Low temperature synchronous
fluorescence spectrophotometry Benzo(a)pyrene 1/2 x 105 Rahn et al. (13)
Fluorometric HPLC assay Benzo(a)pyrene 1/107 Rahn et al. (14)
Photoncounting synchronous
fluorescence spectrophotometry Benzo(a)pyrene 1/16 Vahakangas et al. (15)
Synchronous fluorescence
spectrophotometry Benzo(a)pyrene 1/107 Vahakangas et al. (16)
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FIGURE 1. A schematic representation of a fluorescence spectro-
photometer with a photoncounter.
be detected, for instance one 7-bromomethyl-
benz(a)anthracene molecule could be detected in 20,000
nucleotides (7). Anotherimprovement was synchronous
fluorescence spectrophotometry (SFS). The principle
was presented by Lloyd (8) and developed further by
Vo-Dinh (9,10). The main application ofthe method has
been in analytical chemistry in differentiating between
PAHs in oil mixtures (10,11). Conventional excitation
and emission spectra are often complicated, having many
peaks. By scanning excitation and emission synchron-
ously with a fixed wavelength difference (A X), in some
cases only one peak emerges. This is because a signal
is seen only when A X matches the intervalbetween one
absorption and one emission band (9). Lowtemperature
can increase the fluorescence yield and has also been
used in detection ofcarcinogen-DNA adducts; Ivanovic
et al. (12) were able to detect one benzo(a)pyrene (BP)
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residue per 50,000 nucleotides with conventional fluo-
rescence spectrophotometry after freezing the sample
in 1:1 ethylene glycol at 77°K. Low temperature with
synchronous scanning improves the sensitivity by the
order ofmagnitude compared to low temperature alone
(13). The fluorometric HPLC assay by Rahn et al. (14)
is sensitive enough to detect BP at 1 BP residue per
107 nucleotides.
Results and Discussion
Synchronous scanningispossible, iftheexcitationand
emission monochromators can be locked together and
then scanned with a fixed wavelength difference (A X).
Our first experiments were done with Perkin-Elmer
44B fluorescence spectrophotometer attached to an Or-
tec photon counter (Fig. 1) (15). For the synchronous
scanning we used AX 34 nm (Fig. 2). The correlation
curve between the fluorescence yield at 379 nm ofemis-
sion of in vitro-modified (BPDE)-DNA (± +)-r7,t8-dih-
ydroxy-t9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene
andthe concentration ofBP moieties inthe solution was
linear (Fig. 2). The minimum amount we could detect
wasabout200fmole/mL. Fromsome ofthehuman DNA
samples we could detect the same peak with AX 34 nm
as from BPDE-DNA (Fig. 3).
The main part ofthe studies was done with a Perkin-
Elmer fluorescence spectrophotometer 650-40 with a
Perkin-Elmer3600datastation (16). Thismachine gives
more accuracy, the possibility of three-dimensional
scanning, and mathematical manipulation ofthe curves,
e.g., derivative spectroscopy, and higher sensitivity.
The linear correlation curve between the fluorescence
intensity and concentration of BP moieties was con-
firmed. Because DNA quenchesfluorescence ofBP mol-
ecules covalently bound to it (2,17), we wanted to
compare the fluorescence yields of (r7,t8,t9,clO-tetra-
DNA
HO 00
HO
HO
BENZO(A)PYRENE-7,8-DIOL-
9,10-OXIDE-DNA (BPDE-DNA)
EMISSION
400 450 350
WAVELENGTH (nm)
SYNCHRONOUS
SIGNAL
A - 34 nm
450
FIGURE 2. Excitation (with emission 404 nm), emission (with excitation 355 nm) and synchronous (AX 34 nm) spectra ofBPDE-DNA in Tris-
EDTA buffer at room temperature. A spectral bandpass of 5 nm was used in both excitation and emission monochromators.
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FIGURE 3. Effect of the concentration of BP moieties on the fluo-
rescence yield. BPDE-modified DNA was mixed with unmodified
calf thymus DNA to get the right concentration of BPDE in 20
,ug DNA/mL. Other conditions as in Fig. 2.
hydroxy-7,8,9,10-tetrahydrobenzo(a)pyrene (BP-te-
trol) to that of BPDE-DNA. The differences we saw
between (BP-tetro) and BPDE-DNA were close to those
reported by Rahn et al. (14), BP-tetrol being more flu-
orescent than BPDE-DNA (Fig. 4). Because of this
strong effect and possibly different fluorescence yields
of different adducts (18), the quantitation seemed im-
possible without total hydrolysis of the BPDE-DNA
afterthe isolation and purification ofDNA. This seemed
to be best gained by hydrolyzing in HCl at 90°C (14,16).
Three hours at90°Cin0.1 M HCIwasenoughtoincrease
thefluorescenceyieldsofBPDE-DNAtothe samelevel
with BP-tetrol (Fig. 4).
We are currently applyingthisfluorescence assay and
enzyme immunoassays to study DNA isolated from pe-
ripheralblood lymphocytes (PBL) fromcoke ovenwork-
ers and aluminum plant workers and also to compare
DNA from alveolarmacrophages and PBLs from smok-
ers to that from nonsmokers. There are some earlier
encouraging reports where immunoassays have been
used (19,20).
In one sample of44 coke oven workers (21), we found
about 65% positives at 380 nm with A A 34 nm by SFS.
Of the 10 persons who had a sharp peak at 379 to 380
nm, either after 1 hr or 3 hr heating at 90°C in 0.1 M
HCI, one was anonsmoker, three were ex-smokers, and
six were smokers. We had enough DNA from some of
the coke oven workers to measure adducts by USERIA
(ultrasensitive enzymatic radioimmunoassay) (22,23).
Some ofthe samples positive by SFS were negative by
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FIGURE 4. StandardcurvesforBPDE-DNA(BP-DNA)beforeand
after HCl hydrolysis, and for r7,t8,t9-clO-tetrahydroxy-7,8,9,10-
tetrahydrobenzo(a)pyrene. Conditions as in Fig. 2.
USERIA and vice versa. Although the reasons for the
discrepancies are not totally clear yet, we might spec-
ulate that they could be explained in part by the fact
that USERIA with polyclonal rabbit antiserum detects
BPDE-DNA, whereas BP-GUA and BP-tetrols are
poorly detected by this antiserum (23), and some amount
of hydrolysis is already caused by DNA isolation and
more by storage. By both ofthe methods smokers had
the highest mean adduct levels. In another sample of
36 coke oven workers, four had a sharp peak at 379 nm
after HCl treatment (unpublished results). Of 30 alu-
minum plant workers only one ofthe smokers was pos-
itive (16). Pulmonary alveolar macrophage and
peripheral blood lymphocyte DNAs from both some of
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FIGURE 5. Three-dimensional synchronous spectrum of BPDE-DNA
(BP-DNA). For the first scan AX of 10 nm was used. Total of 28
scans with an increment of 4 nm.
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the healthy smokers and nonsmokers show a peak im-
plying BPDE-DNA adducts (unpublished results).
Conclusion and Perspectives
We are able to detect less than 1 BP moiety per 107
nucleotides in in vitro modified BPDE-DNA by fluo-
rescence using synchronous scanning with AX 34 nm
after hydrolyzing the DNA in 0.1 M HCI at 900C. Ac-
cording to preliminary results, the method should be
usable for biologic monitoring in exposed humans, but
verification of the quantitation and specificity of the
method need in vivo animal experiments.
Further developments ofthe approach include deriv-
ative spectroscopy, which is a routine, powerful, and
useful technique to aid in resolution ofcomplex spectra
(24). An interesting method is three-dimensional scan-
ning (Fig. 5) by which the best AX for new adducts/
compounds might be found. A contour map ofthe three-
dimensional figure makes it possible to find sites ofpeaks
with great accuracy and might provide a kind of"finger
print" in complicated cases (Harris and LaVeck, per-
sonal communication).
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